Chest
-
OSA PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: Home single-channel nasal pressure (HNP) may be an alternative to polysomnography (PSG) for obstructive sleep apnea (OSA) diagnosis but no cost studies have been carried out. Automatic scoring is simpler but generally less effective than manual scoring. Objectives: To determine the diagnostic efficacy and cost of both scorings (automatic and manual) compared with PSG, taking as a polysomnographic OSA diagnosis a clinical-epidemiological apnea-hypopnea index (AHI) cut-off point (≥5) and a clinical-therapeutic AHI cut-off point (≥15). ⋯ The following authors have nothing to disclose: Juan F. Masa, Joaquín Durán-Cantolla, Francisco Capote, Marta Cabello, Jorge Abad, Francisco Garcia-Rio, Antoni Ferrer, Merche Mayos, Nicolás Mangado, Mónica de la Peña, Felipe Aizpuru, Ferran Barbé, Jose M. MontserratNo Product/Research Disclosure Information.
-
ILD Case Report Posters ISESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: Amyloidosis is the abnormal formation of proteins, amyloid fibrins. It is characterised by extracellular deposition in various organs. Pulmonary amyloidosis is rare and can present in the forms of laryngeal, tracheobronchial, pulmonary and mediastinal lymph node disease (1). We present a case of nodular pulmonary amyloidosis in a patient with MCTD. ⋯ Pulmonary amyloidosis is a rare complication of MCTD. Though radiological features can be distinguishing, tissue diagnosis is still the gold standard.Reference #1: Rajagola S, Singh N, Gupta K et al. Pulmonary amyloidosis in Sjogren's Syndrome: A case report and a systemic review of the literature. Respirology (2010) 15, 860-868Reference #2: Ito I, Nagai S, Kitaichi M et al. Pulmonary manifestations of primary Sjogren's syndrome: a clinical, radiologic, and pathologic study. Am. J. Respir. Crit. Care Med. 2005; 171: 632-8.Reference #3: Aylwin AC, Gishen P, Copley SJ. Imaging appearance of thoracic amyloidosis. J Thorac Imaging 2005;20(1):41-46DISCLOSURE: The following authors have nothing to disclose: Chuen Peng Lee, Ser Hon Puah, Wenyuan Sim, Mark Tien, Jessica Pau, Grace Tan, Ruth ChangNo Product/Research Disclosure Information.
-
Cancer Case Report Posters ISESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMPURPOSE: Pilomatrixomas occur most often in the first 2 decades of life.(3)The recuency of pilomatrixoma was 1.04% of the all benign skin lesions.(4)There appears to be a 3:2 female:male incidence ratio, with Caucasians being the most affected group.The most common location of tumor is in the head and neck region. The prognosis is typically good, and the treatment of choice is surgical removal. We report a interestng case of an pilomatrixoma of the upper chest. In a sixth decade of her life ⋯ The following authors have nothing to disclose: Francina Bolanos, Carli Michelle Cardona Landeros, Fernando Arturo Rojo Noriega, Luis Marcelo Argote Greene, Patricio Santillán DohertyNo Product/Research Disclosure Information.
-
Pulmonary Hypertension Posters IISESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: Pulmonary arterial hypertension (PAH; OMIM 178600) is a rare disorder characterized by obstruction of precapillary pulmonary arteries. PAH results from extensive remodelling of the pulmonary vasculature caused by an increased musculation and the fibrosis of the intima that leads to obliteration of small pulmonary arteries. The 75% of patients with familial form of PAH have a mutation in the gene encoding bone morphogenetic protein receptor type II (BMPR2). However, some other candidate genes have been advocated, including the KCNA5 gene that codifies for a potassium voltage-gated channel and ACVRL (Activin A receptor type II-like 1). These genes are located on chromosomes 12p13 and 12q13 respectively. ⋯ The following authors have nothing to disclose: Guillermo Pousada, Adolfo Villar, Carlos Vilariño, Diana ValverdeNo Product/Research Disclosure Information.
-
Thoracic SurgerySESSION TYPE: Slide PresentationsPRESENTED ON: Saturday, March 22, 2014 at 09:00 AM - 10:00 AMPURPOSE: To examine the morbidity, mortality, and efficacy of an Ivor Lewis esophagectomy for esophageal carcinoma , we reviewed our experience. ⋯ The following authors have nothing to disclose: Longsheng Miao, Haiquan Chen, Jiaqing Xiang, Yawei Zhang, Bin LiNo Product/Research Disclosure Information.